HEIDELBERG PHARMA AG O.N./ DE000A11QVV0 /
| 2024-11-15 5:36:11 PM | Chg. -0.060 | Volume | Bid2024-11-15 | Ask2024-11-15 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.280EUR | -2.56% | 1,002 Turnover: 2,287.490 |
-Bid Size: - | -Ask Size: - | 77.92 mill.EUR | 0.00% | - |
Assets
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1.3000 | 1.3000 | 1.9000 | 2.4000 | 3.1000 | ||||||
| Intangible Assets | 2.8000 | 2.8000 | 2.8000 | 2.8000 | 2.8000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 10.3000 | 10.3000 | 10.9000 | 11.4000 | 12.1000 | ||||||
| Inventories | .2000 | .2000 | .2000 | .2000 | .2000 | ||||||
| Accounts Receivable | .0900 | .3000 | .4000 | 1.2000 | 1.2000 | ||||||
| Cash and Cash Equivalents | 4.6000 | 30.4000 | 19.4000 | 9.9000 | 5 | ||||||
| Current Assets | 5 | 31.2000 | 20.3000 | 11.6000 | 7.5000 | ||||||
| Total Assets | 15.2000 | 41.5000 | 31.2000 | 23 | 19.6000 | ||||||
Liabilities
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .1000 | 1.5000 | .4000 | 1 | 2.8000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 3.7000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | .4000 | .4000 | - | - | - | ||||||
| Liabilities | 5.5000 | 4.5000 | 5.3000 | 6.7000 | 6.7000 | ||||||
| Share Capital | 12.9280 | 22.4530 | 28.1330 | 28.2090 | 31.0620 | ||||||
| Total Equity | 9.8000 | 37 | 25.9000 | 16.3000 | 12.9000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 15.2000 | 41.5000 | 31.2000 | 23 | 19.6000 | ||||||
Income Statement
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2.7000 | 1.9000 | 3.7000 | 7.3000 | 8.5000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -6.4000 | -10.8000 | -11.7000 | -10.1000 | -18.3000 | ||||||
| Interest Income | -.0190 | -.2000 | - | - | -.0100 | ||||||
| Income Before Taxes | -6.4000 | -11 | -11.7000 | -10.1000 | -18.4000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | .0050 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -6.4000 | -11 | -11.7000 | -10.1000 | -18.4000 | ||||||
Per Share
Cash Flow
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -6.5000 | -7.9000 | -9.9000 | -8.6000 | -17.9000 | ||||||
| Cash Flow from Investing Activities | -.5000 | -.4000 | -1 | -1 | -1.3000 | ||||||
| Cash Flow from Financing | 10.3000 | 34.2000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Decrease / Increase in Cash | 3.3000 | 25.8000 | -10.9000 | -9.6000 | -4.9000 | ||||||
| Employees | 53 | 58 | 62 | 69 | 84 | ||||||
